Marinus Pharmaceuticals Q4 2024 Earnings Report

Expected Revenue:$10.6M
+33.0% YoY
Expected EPS:-$0.35
+45.3% YoY

Marinus Pharmaceuticals

Marinus Pharmaceuticals